CHRISTIAN ROMERO: Open Payments
NPI 1942806237 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 31 payments from 11 companies in 2025. Trend: 2023 $157 · 2024 $223 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 9 | $255 |
| AstraZeneca Pharmaceuticals LP | 5 | $220 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| GlaxoSmithKline, LLC. | 2 | $65 |
| Novo Nordisk Inc | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| PFIZER INC. | 2 | $31 |
| Hologic Sales and Service, LLC | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
Products named: REZDIFFRA, FARXIGA, TEZSPIRE, AREXVY, Kerendia, NURTEC ODT, APTIMA, XIFAXAN.
Industry payments across CA — which companies pay providers there.
